Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex

被引:0
作者
Hack, AA
Lam, MYJ
Cordier, L
Shoturma, DI
Ly, CT
Hadhazy, MA
Hadhazy, MR
Sweeney, HL
McNally, EM [1 ]
机构
[1] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA
[3] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA
[4] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA
关键词
sarcoglycan; dystrophin; muscle; extracellular matrix;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Sarcoglycan is a multimeric, integral membrane glycoprotein complex that associates with dystrophin, Mutations in individual sarcoglycan subunits have been identified in inherited forms of muscular dystrophy, To evaluate the contributions of sarcoglycan and dystrophin to muscle membrane stability and muscular dystrophy, we compared muscle lacking specific sarcoglycans or dystrophin. Here we report that mice lacking delta-sarcoglycan developed muscular dystrophy and cardiomyopathy similar to mice lacking gamma-sarcoglycan. However, unlike muscle lacking gamma-sarcoglycan, delta-sarcoglycan-deficient muscle was sensitive to eccentric contraction-induced disruption of the plasma membrane. In the absence of delta-sarcoglycan, alpha-, beta- and gamma-sarcoglycan were undetectable, while dystrophin was expressed at normal levels. In contrast, without gamma-sarcoglycan, reduced levels of alpha-, beta- and delta-sarcoglycan were expressed, glycosylated and formed a complex with each other. Thus, the elimination of gamma- and delta-sarcoglycan had different molecular consequences for the assembly and function of the dystrophin-glycoprotein complex. Furthermore, these molecular differences were associated with different mechanical consequences for the muscle plasma membrane. Through this in vivo analysis, a model for sarcoglycan assembly is proposed.
引用
收藏
页码:2535 / 2544
页数:10
相关论文
共 41 条
[1]   Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in β-sarcoglycan-deficient mice [J].
Araishi, K ;
Sasaoka, T ;
Imamura, M ;
Noguchi, S ;
Hama, H ;
Wakabayashi, E ;
Yoshida, M ;
Hori, T ;
Ozawa, E .
HUMAN MOLECULAR GENETICS, 1999, 8 (09) :1589-1598
[2]   Ecto-ATPase activity of α-sarcoglycan (adhalin) [J].
Betto, R ;
Senter, L ;
Ceoldo, S ;
Tarricone, E ;
Biral, D ;
Salviati, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :7907-7912
[3]  
Bonnemann Carsten G., 1996, Current Opinion in Pediatrics, V8, P569
[4]   X-CHROMOSOME-LINKED MUSCULAR-DYSTROPHY (MDX) IN THE MOUSE [J].
BULFIELD, G ;
SILLER, WG ;
WIGHT, PAL ;
MOORE, KJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (04) :1189-1192
[5]   The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms [J].
Bushby, KMD .
HUMAN MOLECULAR GENETICS, 1999, 8 (10) :1875-1882
[6]   3 MUSCULAR-DYSTROPHIES - LOSS OF CYTOSKELETON EXTRACELLULAR-MATRIX LINKAGE [J].
CAMPBELL, KP .
CELL, 1995, 80 (05) :675-679
[7]   Molecular organization of sarcoglycan complex in mouse myotubes in culture [J].
Chan, YM ;
Bönnemann, CG ;
Lidov, HGW ;
Kunkel, LM .
JOURNAL OF CELL BIOLOGY, 1998, 143 (07) :2033-2044
[8]   Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy [J].
Coral-Vazquez, R ;
Cohn, RD ;
Moore, SA ;
Hill, JA ;
Weiss, RM ;
Davisson, RL ;
Straub, V ;
Barresi, R ;
Bansal, D ;
Hrstka, RF ;
Williamson, R ;
Campbell, KP .
CELL, 1999, 98 (04) :465-474
[9]  
Culligan KG, 1998, INT J MOL MED, V2, P639
[10]   Progressive muscular dystrophy in α-sarcoglycan-deficient mice [J].
Duclos, F ;
Straub, V ;
Moore, SA ;
Venzke, DP ;
Hrstka, RF ;
Crosbie, RH ;
Durbeej, M ;
Lebakken, CS ;
Ettinger, AJ ;
van der Meulen, J ;
Holt, KH ;
Lim, LE ;
Sanes, JR ;
Davidson, BL ;
Faulkner, JA ;
Williamson, R ;
Campbell, KP .
JOURNAL OF CELL BIOLOGY, 1998, 142 (06) :1461-1471